The outcome of Crohn's disease
β Scribed by J. D. Atwell; H. L. Duthie; J. C. Goligher
- Publisher
- John Wiley and Sons
- Year
- 1965
- Tongue
- English
- Weight
- 782 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: The Crohn's Disease Activity Index (CDAI) has become the gold standard for assessment of disease activity in CD. This study investigated the relationship between CDAI and the physicians' global assessment of disease activity (PGA) and whether different demographic and disease-related fac
## Background: Infliximab (ifx) is an effective therapy for refractory luminal and fistulizing crohn's disease (cd). predictors of response could improve selection of patients with a higher probability of favorable outcomes and could improve the safety profile. we aimed to develop a predictive mode
Eighty-three patients with long-standing Crohn's disease (CD) were retrospectively reviewed to determine whether natural history and clinical outcome were different and a patient subgroup classification could be reliably adopted. In all patients, the initial anatomical location, the "behavioral patt